We are live on ! Find out more
AGRX

Agile Therapeutics

Delisted

AGRX was delisted on the 25th of March, 2024.

61 hedge funds and large institutions have $61.4M invested in Agile Therapeutics in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $294K

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

33% more funds holding

Funds holding: 4661 (+15)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less capital invested

Capital invested by funds: $68.1M → $61.4M (-$6.6M)

Holders
61
Holders Change
+15
Holders Change %
+32.61%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
17
Reduced
10
Closed
11
Calls
$1.03M
Puts
$294K
Net Calls
+$734K
Net Calls Change
+$365K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
-$6K -1 Closed